| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |